Efficacy and Safety of Potenfill for Temporary Penile Enhancement
Not Applicable
Completed
- Conditions
- Penile Enhancement
- Registration Number
- NCT03512717
- Lead Sponsor
- Medy-Tox
- Brief Summary
The purpose of this study is to evlauate the efficacy and safety of poteinfill, compared to the powerfill.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 76
Inclusion Criteria
- Male subjects aged above 19 and below 65. (20≤male≥65)
- be rating himself, when screening, as "Small or Very Small" on Self-Questioned Questionnaire ( SQQ) including the question: " How do you rate your penile size? // Very small, Small, Normal, Big, Very Big?"
- Subjects will sign an informed consent form
Exclusion Criteria
- Prior treatment for penile enhancement (e.g. fat, dermal graft).
- Subjects who have penile malformation (e.g. Peyronie's disease), which can make impossible to perform the intervention
- Allergic to hyalluronic acid.
- Inflammatory or/and infectious disease on penis that can affect on this study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method the Penile Circumference difference at 24 weeks from baseline 24 weeks Penile Circumference: The average of Distal-, Mid-, and Proximal-penis measurements when relaxed by tape measurement
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Potenfill's temporary penile enhancement effects compared to Powerfill?
How does Potenfill's efficacy and safety profile compare to standard penile enhancement devices like vacuum pumps?
Are there biomarkers associated with response to injectable penile enhancement therapies similar to Potenfill?
What adverse events were reported in Medy-Tox's NCT03512717 trial and how were they managed?
How do combination therapies involving Potenfill and PDE5 inhibitors compare to monotherapy in penile enhancement outcomes?
Trial Locations
- Locations (1)
Gangdong Sacred Heart Hospital, Hallym Univ
🇰🇷Seoul, Korea, Republic of
Gangdong Sacred Heart Hospital, Hallym Univ🇰🇷Seoul, Korea, Republic of